A research team has developed an innovative nanomotor-based strategy to improve immunotherapy for bladder cancer. The study, ...

The following is a summary of “GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis,” published in the February 2025 ...

During a live event, participating oncologists discuss the role of ctDNA and molecular testing in muscle-invasive bladder ...

Discover recent findings that highlight the potential for urinary DNA methylation testing to improve early detection and diagnosis of bladder cancer.

A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less ...

My pet provided emotional support and helped me tolerate chemotherapy better, reducing my stress and improving my well-being throughout my cancer journey.

Neoadjuvant chemoimmunotherapy for muscle-invasive bladder cancer (MIBC) followed by risk-adapted therapy led to high rates ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...

Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...

Bottom line: Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the ... Garcia-del-Muro considered the regimen well-tolerated. The incidence of grade 3 or 4 ...